Peptides for Kidney Disease Overview: A Clinical Perspective

Written by Adam Maggio | Medically reviewed by Dr. Sarah Chen, PharmD, BCPS

Peptide therapies offer a promising new approach for managing kidney diseases by targeting inflammation, oxidative stress, and fibrosis. Emerging platforms like nano-organo peptides and mitochondria-targeted peptides show potential for precise, localized treatment and improved outcomes.

{" ".join(current_paragraph)}